CLEMENTIA PHARMACEUTICALS IN - COM (CMTA)

CUSIP: 185575107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
29,952,756
Share change
+6,396,543
Total reported value
$352,113,880
Price per share
$11.76
Number of holders
31
Value change
+$75,183,771
Number of buys
24
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 185575107?
CUSIP 185575107 identifies CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) as of Q4 2018

As of 31 Dec 2018, CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,952,756 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, JPMORGAN CHASE & CO, DRIEHAUS CAPITAL MANAGEMENT LLC, Artal Group S.A., and Partner Fund Management, L.P.. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.